Many causes contribute to the development of cell apoptosis during stroke pathologies, such as ATP depletion and free radicals leading to cell apoptosis of neurons and glial cells, calcium influx leading to cell apoptosis of neurons and oligodendrocytes, and inflammatory response and α-syn aggregation inducing cell apoptosis of neurons. Although the end result is the occurrence of cell apoptosis, the pathological processes that occur in different conditions are quite different. That can also reflect, to some extent, the pathological processes experienced in stroke. Therefore, Ace Therapeutics offers comprehensive services to explore the role of cell apoptosis in the pathological process of stroke.
Ace Therapeutics provides high - quality services to identify cell apoptosis during stroke pathology.
During the stroke, calcium overload leads to mitochondrial dysfunction, which in turn leads to the development of cell apoptosis. In view of this, Ace Therapeutics provides comprehensive services to explore mitochondrial - mediated cell apoptosis.
Dysregulation of calcium homeostasis leads to the accumulation and aggregation of unfolded proteins, resulting in a severe endoplasmic reticulum stress response and the appearance of endoplasmic reticulum-mediated cell apoptosis. However, this apoptotic pathway has been less studied in stroke pathology. Therefore, Ace Therapeutics provides comprehensive biological services to explore its role in the pathology of stroke.
The death receptor pathway is initiated by external factors and induces cell apoptosis. Ace Therapeutics provides comprehensive services to explore the specific role of death receptor pathway-mediated cell apoptosis in stroke pathology.
Ace Therapeutics offers a one-stop scientific service plat to explore the role of cell apoptosis in stroke in a scientific and accurate manner. If you would like to learn more about our services, please feel free to contact us.
We are committed to accelerating progress in stroke research and drug development.